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The rapid expansion of carbapenem-resistant Acinetobacter baumannii (CRAB) clinical
isolates is a big issue. We investigated the antibiotic susceptibility, molecular
epidemiology and resistance gene of A. baumannii collected at two hospitals in
Shanghai, China. Besides, the A. baumannii PCR-based replicon typing method (AB-
PBRT) was conducted to categorize the plasmids into homogeneous groups on the
basis of replicase genes. Most CRAB isolates showed high-level resistance to almost
all antibiotics but retain susceptibility to colistin and tigecycline. A total of 101 isolates
carried blaOXA 51-like gene. Sequencing identified the presence of bla for− OXA−66 CRAB
isolates. blaOXA 23 gene were discovered in all CRAB isolates. Each CRAB isolate−
contained 1–3 of 19 different plasmid replicase (rep) gene homology groups (GRs)
and the GR6 (repAci6) was ubiquitous. Genotyping by Multilocus Sequence Typing
(MLST) showed seven defined MLST patterns and three novel STs were found. eBURST
analysis indicated they were all grouped in CC92 (GCII) with the most frequent ST208
(50%). Two blaOXA 23-bearing transposons were found: Tn2006 and Tn2008. Tn2008−
were detected in 54 (96.4%) isolates and Tn2006 in two remaining isolates. The
blaOXA 23 carbapenem gene was vitally associated with repAci6 plasmid belong to−
CC92 clonal group. Our survey revealed severe drug resistance in A. baumannii isolates.
Tn2008-containing CC92 A. baumannii were endemic, which may facilitate the blaoxa23
dissemination.
Keywords: carbapenem-resistant Acinetobacter baumannii (CRAB), blaOXA−23, transposon, plasmid replicase
genes, multilocus sequence type (MLST)
INTRODUCTION
Acinetobacter baumannii is a significant opportunistic pathogen responsible for numerous
nosocomial infections, including respiratory infections (in particular ventilator-associated
pneumonia, VAP), urinary tract infections, bacteremia, soft and skin tissue infections, burn wound
infections and secondary meningitis (Roca et al., 2012; Kempf et al., 2013). Carbapenem resistance
in A. baumannii is an emerging problem worldwide during the last decade (Jiang et al., 2014;
Guerrero-Lozano et al., 2015). One data from Taiwan involving five major hospitals showed that
resistance to imipenem in intensive care units increased from 22.0% in 2000 to 66.8% in 2010
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(Hsueh et al., 2001). Studies performed by Reddy also reported
a disturbing tendency of sharp increase in the rates of CRAB
isolates, from 1% in 2003 to 58% in 2008 (Reddy et al., 2010).
Data from Wallace also found the percentage of CRAB isolates
was 31% before the year 2009 followed by 99% after the year 2009
at the University of Maryland Medical Center (UMMC; Wallace
et al., 2016).
Carbapenem-resistant in A. baumannii is due to combined
mechanisms including production of OXA- and metallo-
β-lactamases, outer membrane impermeability, increased
expression of eﬄux pumps, and penicillin-binding proteins
modification (Zarrilli et al., 2013). OXA-type enzymes related
to carbapenem resistance include the natural blaOXA−51-like
and three acquired genes: blaOXA−23-like, blaOXA−24-like and
blaOXA−58-like (Jiang et al., 2014). These genes were integrated
in the bacterial chromosome or carried by plasmids (Poirel
et al., 2010). Nowadays, AB-PBRT method provides a new tool
to investigate the epidemiology of plasmids in A. baumannii
(Towner et al., 2011). Numerous publications reported the
spread of resistance gene via transposons (Poirel et al., 2010).
Four transposons harboring blaoxa−23 gene have been reported:
Tn2006, Tn2007, Tn2008, and Tn2009 (Zhou et al., 2011;
Espinal et al., 2013; Guerrero-Lozano et al., 2015). These types
of transposons share a common region “blaOXA−23-1ATPase.”
Tn2007 owns ISAba4 promoter upstream blaOXA−23 gene. The
remaining three transposons own ISAba1. The two ISAba1
copies were inversely orientated in Tn2006 compared to the
same direction in Tn2009 (Guerrero-Lozano et al., 2015). Tn2006
and Tn2008 are reported globally disseminated, while Tn2009
has only been discovered in China (Zhou et al., 2011). These
ISAba1-associated transposons contributed to the dissemination
of blaOXA−23. Moreover, Tn2006, Tn2008, and Tn2009 all have
been found in conjugative plasmids except Tn2007. It is noted
that Tn2007 is immovable and is not actually considered as a
transposon (Nigro and Hall, 2016).
Colistin is currently used as last-resort antibiotics against
CRAB infection (Durante-Mangoni et al., 2014). It is important
to analyze the local epidemiology of clinical CRAB isolates and
control the dissemination. The aim of the present study was
to investigate the drug-resistance and molecular characteristics
of A. baumannii isolates in 101 A. baumannii clinical isolates
from two hospitals in Shanghai. We also characterized the
genetic environment surrounding blaOXA−23 gene. In addition,
the distribution and epidemiology of plasmid replicase (rep)
genes in CRAB isolates were also investigated.
MATERIALS AND METHODS
Bacterial Isolates
A total of 101 non-repetitive A. baumannii clinical isolates
were collected in this study from two hospitals in Shanghai,
China. All subjects were anonymised in this study. Eighty-seven
isolates were recovered from neurosurgery in Renji Hospital
Shanghai Jiaotong University School of Medicine from July 2011
to June 2013. And the remaining 14 isolates were collected from
Obstetrics and Gynecology Hospital of Fudan University from
January 2015 to August 2016. All isolates were identified using
the VITEK 2 Compact automatic bacteria and drug susceptibility
analysis system.
Antimicrobial Susceptibility Testing
Antibiotic susceptibility testing was conducted in the present
study. Fourteen antimicrobial agents were tested including
piperacillin/tazobactam, cefoxitin, ceftazidime, cefotaxime,
imipenem, meropenem, gentasin, amikacin, minocycline,
ciprofloxacin, trimethoprim/sulfamethoxazole, cefepime,
polymyxin, and tigecycline. The Minimum inhibitory
concentrations (MICs) were determined by agar dilution
method except polymyxin, which was performed by broth
dilution method. Pseudomonas aeruginosa ATCC 27853 and
Escherichia coli ATCC 25922 were used as reference strains.
The susceptibility results were interpreted based on the Clinical
and Laboratory standards Institute (CLSI) breakpoints (CLSI,
2011). For tigecycline, we used breakpoints recommended by
the British Society for Antimicrobial Chemotherapy guidelines
(BSAC, 2011). CRAB isolates were defined with both imipenem
and meropenem resistance (MICs> 8 mg/L).
PCR and Sequencing of Drug Resistance
Genes
PCR assay was performed to screen the presence of drug
resistance genes in 101 isolates, including blaOXA−23-like,
blaOXA−24-like, blaOXA−51-like, blaOXA−58-like, blaIMP−1,
blaVIM−1, blaVIM−2, and blaAmpC. The entire products were
sequenced and analyzed with the BLAST website1.
Multilocus Sequence Typing
Molecular typing of CRAB isolates was determined by MLST.
Briefly, it was detected by sequence analysis of gltA, gyrB, gdhB,
recA, cpn60, gpi, and rpoD housekeeping genes as previously
described (Ying et al., 2015). Primers are available at http://
pubmlst.org/abaumannii/. The results were compared with the
STs databases online at http://pubmlst.org/databases/. eBURST
analysis was conducted to investigate the genetic relationships
and clonal complexes (CCs) of these isolates.
Genetic Environment of the blaOXA−23
Gene
PCR was performed to detect the occurrence of blaOXA−23-
carrying transposons in CRAB isolates, including Tn2006,
Tn2007, Tn2008, and Tn2009. Primers used in this study were
shown in Table 1. Structures and primer locations were shown
in Figure 1. In addition, blaoxa−23−1ATPase was the common
region of Tn2006 and Tn2008.
AB-PBRT
Nineteen PCR amplifications were organized into six multiplexes
and used to detect 27 different plasmid rep genes as described
previously (Bertini et al., 2010). Each PCRs recognized three
or four different homology groups (GRs). PCR products were
1http://www.ncbi.nlm.nih.gov/blast
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TABLE 1 | Primers used for blaOXA−23 gene detection.
Primer name Primer sequence (5′ –3′ ) Replicase gene
Tn2006 Int-P3 GTCTATCAGGAACTTGCGCG ISAba1-blaoxa−23-
ISAba1
Tn2006 Int-P4 GCAAGGCTTTAGATGCAGAAGA
Tn2007 Int-P6 ATTTGAACCCATCTATTGGC ISAba4- blaoxa−23
Tn2007 Int-P7 ACTCTCATATTTTTTCTTGG
Tn2006/8 Int-P3 GTCTATCAGGAACTTGCGCG blaoxa−23−1ATPase
Tn2006/8 Int-P5 GGCTCATTACAGTCAGGTACAAGT
Tn2009 Int-P1 ATCCTGATGCTCGCAATCGT ISAba1-blaoxa−23-
ISAba1
Tn2009 Int-P8 CTGTCTGCGAACACATTCAC
recognized by DNA sequencing. An additional PCR was
performed to identify the gene encoding the type IV secretion
system protein TraC, which was found on the plasmid pACICU2
carrying the repAci6 gene (Towner et al., 2011).
RESULTS
Antimicrobial Susceptibility Testing
The MICs of 14 antimicrobial agents were determined for all
A. baumannii isolates. Sixty-five (64.4%) and 70 (69.3%) strains
were resistant to imipenem and meropenem (Table 2). Fifty-six
CRAB isolates were recovered and the MICs of imipenem and
meropenem were both ranged from 16 to 256 mg/L. Resistance
to piperacillin/tazobactam, cefoxitin, ceftazidime, cefotaxime,
cefepime, gentamicin, amikacin, minocycline, ciprofloxacin, and
trimethoprim/sulfamethoxazole were 71.3% (72/101), 87.1%
(88/101), 75.2% (76/101), 85.1% (86/101), 69.3% (70/101), 74.3%
(75/101), 62.4% (63/101), 27.7% (28/101), 74.3% (75/101), and
88.1% (89/101), respectively. However, no isolate was resistant
to colistin or tigecycline. The MICs of antimicrobial agents for
isolates recovered from Renji Hospital were higher than those
from Fudan Obstetrics and Gynecology hospital. In addition, 14
isolates from Fudan Obstetrics and Gynecology hospital were all
sensitive to imipenem and meropenem (Table 2).
Detection of Drug Resistance Genes
PCR screening was performed to detect drug resistant genes in all
isolates. The natural oxacillinase, blaOXA−51-like, were detected
in all isolates. And blaOXA−51-like gene of CRAB strains revealed
the presence of blaOXA−66 by sequencing. The prevalence of
blaOXA−23 and blaAmpC gene was 60.4% (61/101) and 51.5%
(52/101). Besides, all 56 CRAB isolates contained blaOXA−23
genes and 54 CRAB isolates contained blaAmpC. The genes
encoding blaOXA−24/58-like, blaIMP−1 and blaVIM−1/2 were not
detected in any of the 101 isolates.
Multilocus Sequence Typing
Fifty-six CRAB isolates were typed by MLST analysis. A total of
seven defined STs and three novel STs were identified. ST208,
FIGURE 1 | Structures and primer locations of Tn2006, Tn2007, Tn2008, and Tn2009.
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TABLE 2 | Susceptibility analyses of 101 A. baumannii in this study.
Antimicrobial agents RJa (n = 87) OGb (n = 14) N = 101
R (n, %c) R (n, %) R (n, %)
Piperacillin/Tazobactam 72, 82.8% 0, 0 72, 71.3%
Cefoxitin 80, 91.9% 8, 57.1% 83, 87.1%
Ceftazidime 73, 83.9% 3, 21.4% 76, 75.2%
Cefotaxime 83, 95.4% 3, 21.4% 86, 85.1%
Cefepime 70, 80.5% 0, 0 70, 69.3%
Imipenem 65, 74.7% 0, 0 65, 64.4%
Meropenem 70, 80.5% 0, 0 70, 69.3%
Gentamicin 75, 86.2% 0, 0 75, 74.3%
Amikacin 63, 72.4% 0, 0 63, 62.4%
Minocycline 28, 32.2% 0, 0 28, 27.7%
Ciprofloxacin 75, 86.2% 0, 0 75, 74.3%
Trimethoprim-sulfamethoxazole 87, 100% 2, 14.3% 89, 88.1%
Tigecycline 0, 0 0, 0 0, 0
Colistin 0, 0 0, 0 0, 0
aRJ, Renji Hospital Shanghai Jiaotong University School of Medicine; bOG,
Obstetrics and Gynecology Hospital of Fudan University; c%R, Resistant percent.
which accounting for the largest proportion (28/56, 50.0%), was
the major clonal type, followed by ST191 (12/56, 21.4%), ST540
(7/56, 12.5%), ST381 (2/56, 3.57%), ST643 (2/56, 3.57%), ST195
(1/56, 1.79%), and ST368 (1/56, 1.79%). Additionally, they were
single locus variants of gpi gene. eBURST analysis (Figure 2)
showed that the seven defined STs along with novel STs were all
clustered into the same CCs (CC92), which was also commonly
referred to as global/international clone II (GCII; Diancourt et al.,
2010; Zarrilli et al., 2013). The three novel STs were submitted and
have assigned as ST1472, ST1473, and ST1474, respectively.
Genetic Structure of blaOXA−23 Gene
The gene encoding blaOXA−23 of 56 CRAB isolates was located
exclusively within the Tn2006 or Tn2008 transposons. We found
Tn2008 was almost ubiquitous (54 of 56 isolates). However, the
specific region (ISAba1-blaoxa−23-ISAba1) for Tn2006 was only
detected in 2 (3.6%) isolates. No ISAba4- blaoxa−23 was found,
indicating there was no Tn2007 in these CRAB strains, followed
by the Tn2009.
Distribution of Plasmid rep Genes
GR6 (repAci6) was the most prevalent and detected in 52 CRAB
isolates along with TraC gene, which was identified on plasmid
pACICU2 (Table 3). GR14 (p4AYE) was found in 29 CRAB
isolates, followed by GR8 (Aci9, found in 11 isolates), GR2 (Aci1,
5 isolates), GR4 (Aci4, 3 isolates), and GR12 (p2S1, 1 isolate).
The plasmid rep gene profiles and CHDL content along with the
general typing of 56 CRAB isolates were summarized in Table 3.
DISCUSSION
The increasing drug resistance of A. baumannii has raised a big
challenge, especially CRAB strains reported worldwide (Durante-
Mangoni et al., 2014). As observed in other literature, here we
reported a high prevalence of carbapenem resistance (55.4%)
in clinical A. baumannii isolates recovered from two hospitals.
Most CRAB strains always exhibited high resistance to other
antimicrobial agents tested.
OXA-type carbapenems resistance hydrolytic enzymes are
common in A. baumannii isolates. blaOXA−51-like gene, which
shares less than 60% amino acid identity with other OXA-
types, was identified in all A. baumannii isolates, supporting
that blaOXA−51-like are natural genes in A. baumannii (Table 3).
blaOXA−66 variant might be the most prevalent and found in
all 56 CRAB isolates. In general, CRAB strains contained more
resistance genes. This probably explains why CRAB strains
show much higher MICs than non-CRAB isolates. blaOXA−24-
like β-lactamases was first identified in A. baumannii in 1997,
FIGURE 2 | eBURST analysis results of tested CRAB isolates. One clonal complexes (CC92) were identified. The size of the dot indicates the number of CRAB
isolates.
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TABLE 3 | Results of plasmid rep geng groups of 56 CRAB isolates.
GR group (repAci) Isolate(s) Resistance genes content Transposons MLST
OXA-23 OXA-66 AmpC
6 60, 80 + + + Tn2008 ST208
25 + + + Tn2008 ST191
36 + + + Tn2006 ST381
56 + + − Tn2008 ST208
2 53, 69 + + + Tn2008 ST208
23, 26 + + + Tn2008 ST191
6, 8 C3, C26, 19, 21, 22, 24, 30, 33, 50, 55, 57, 61, 63, 82, 91, + + + Tn2008 ST208
C22, + + + Tn2008 ST1472
C23, + + + Tn2008 ST1473
39 + + + Tn2008 ST1474
6, 14 18, 28, 32, 37, 40, 41, 59, 76, 88 + + + Tn2008 ST191
C27, 64, 65, 66, 67, 83 + + + Tn2008 ST540
45, 49, 51 + + + Tn2008 ST208
20, 35 + + + Tn2008 ST643
C7 + + + Tn2008 ST368
52 + + − Tn2008 ST208
62 + + + Tn2006 ST540
34 + + + Tn2008 ST381
2, 6, 14 48 + + + Tn2008 ST195
6, 12, 14 C20 + + + Tn2008 ST208
4, 6, 8 71, 84, 85 + + + Tn2008 ST208
+, positive; −, negative.
which resulted in an outbreak in Spain (Bou et al., 2000).
AndblaOXA−58-like gene was first found in France in 2003 (Poirel
et al., 2005). Isolates carrying blaOXA−24/58-like genes were
typically resistant to carbapenems. Fortunately, they were barely
identified in China. Our results also indicated no blaOXA−24/58-
like nor blaIMP−1 genes were found. However, due to their
plasmid location, the distribution of these genes in A. baumannii
should be early monitored.
Multilocus Sequence Typing is frequently used for strain
phylogeny and global epidemiology. Fifty-six CRAB isolates with
occurrence of blaOXA−23 in our study were typed. The most
common ST was ST208 and CC92 was the unique CC clonal
group tested. CC92 (GCII) clone outbreaks due to blaOXA−23-
producing A. baumannii strains have been reported frequently
(Fu et al., 2010; He et al., 2011). The discovered of three
novel STs indicated that A. baumannii isolates were diverse and
still clonal expansion. Our e-BURST analysis revealed clonal
spread at Renji hospital during a certain period. Hence the
carbapenems resistance in A. baumannii is increasing. While
isolates of the same ST clone reported owning different resistance
patterns, the vital spreading of CRAB isolates may have other
approaches.
Acinetobacter baumannii PCR-based replicon typing assay
revealed 52 CRAB isolates owning repAci6, and the gene
encoding TraC was strongly linked with repAci6 plasmid. No
rep genes associated with blaOXA−24/58 were found. RepAci6 was
identified on plasmid pACICU2 in general and TraC protein
make pACICU2 transferable (Iacono et al., 2008). In some cases
(e.g., isolates Ab18 and Ab64), different MLST genotypes were
found to have identical plasmid rep gene profiles. In contrast
(e.g., isolates Ab18 and Ab23), isolates with the same MLST type
were found to have different plasmid rep gene profiles (Table 3).
Hence the plasmid rep genes were variable in the process of strain
epidemics. blaOXA−23-like gene was associated with carriage of
repAci6 plasmids as previously described (Towner et al., 2011).
With few exceptions, strains grouped in ST208 were associated
with pACICU2, pMAC02, and p4AYE. Strains grouped in ST191
and ST540 were associated with carriage of pACICU2 and
p4AYE. These removable plasmids carrying CHDLs genes led to
spreading among A. baumannii strains.
As we mentioned, the spread of carbapenems resistance
gene in A. baumannii are of great importance. One of the
most popular gene blaOXA−23 was discovered here. Of four
transposons reported, Tn2006 and Tn2008 were identified in
CRAB isolates, both of which were flanked by ISAba1. However,
Tn2007 and Tn2009 are not seen in agreement with previous
researches. It was noted that ISAba1 facilitated the mobilization
of blaOXA−23 gene hence allowed Tn2006 and Tn2008 to move.
These four transposons were observed in plasmids as well as
in the chromosome of A. baumannii (Nigro and Hall, 2016).
Besides, Tn2006, Tn2007, and Tn2008 were found in different
locations of conjugative repAci6 group plasmids (Nigro and Hall,
2015). It seemed that the blaOXA−23 dissemination might due to
transposition of mentioned transposons.
Our survey suggested that both clonal spread of a GC2
strain carrying carbapenems resistance genes and the spread of
conjugative plasmid among A. baumannii strains are responsible
for the serious increasing carbapenems resistance. Further
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understanding of related plasmids may help determine their
acquisition, dissemination and regulation among A. baumannii.
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